Yayın: Development and efficacy of a novel monoclonal antibody targeting CX3CR1 for pain relief in pancreatic cancer and chronic pancreatitis
| dc.contributor.advisor | supervisor Güralp Onur Ceyhan | |
| dc.contributor.author | Baybağ, Deniz | |
| dc.date.accessioned | 2026-07-30T12:34:36Z | |
| dc.date.issued | 2024-01-01 | |
| dc.department | Department of Medical Biotechnology | |
| dc.format.extent | vi, 76 s. | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/10338 | |
| dc.institution | Institute Of Health Sciences | |
| dc.language.iso | en | |
| dc.publisher | Acıbadem Mehmet Ali Aydınlar Üniversitesi | |
| dc.subject | Antibody | |
| dc.subject | CX3CR1 | |
| dc.subject | Fractalkine | |
| dc.subject | Hybridoma | |
| dc.subject | Chronic pancreatitis | |
| dc.title | Development and efficacy of a novel monoclonal antibody targeting CX3CR1 for pain relief in pancreatic cancer and chronic pancreatitis | |
| dc.type | masterthesis | |
| dspace.entity.type | Publication |
Dosyalar
Orijinal seri
1 - 1 / 1
Yükleniyor...
- Ad:
- Development and efficacy of a novel monoclonal antibody targeting CX3CR1 for pain relief in pancreatic cancer and chronic pancreatitis.pdf
- Boyut:
- 25.32 MB
- Format:
- Adobe Portable Document Format
Lisanslı seri
1 - 1 / 1
Yükleniyor...
- Ad:
- license.txt
- Boyut:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Açıklama
